Cardiovascular magnetic resonance (CMR) has become an established non-invasive imaging modality for the diagnosis of ischemic heart disease (IHD) and contributes important information for therapeutic decisions regarding revascularization. For the identification of ischemia, CMR provides two methods, which are routinely used in clinical practice. Ischemia can be visualized either as regional hypoperfusion when using CMR-perfusion imaging during vasodilator induced hyperaemia, or as impaired regional wall motion under dobutamine stress CMR. CMR has proven its robustness, diagnostic performance and prognostic value in patients with IHD in several multicenter trials.
This abstract and the presentation materials are available to members only; a login is required.